Noriaki Usui

Dr. Noriaki Usui


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2022 in Children
Verified
Journal Article
Open access
PDF file
MYMasaya Yamoto
Masaya Yamoto
KNKouji Nagata
Kouji Nagata
KTKeita Terui
Keita Terui
MHMasahiro Hayakawa
Masahiro Hayakawa
HOHiroomi Okuyama
Hiroomi Okuyama
NUNoriaki Usui
Noriaki Usui
Background: Treatment modalities for neonates with congenital diaphragmatic hernia (CDH) have greatly improved in recent years, with a concomitant increase in survival. However, long-term outcomes restrict the identification of optimal care pathways for CDH survivors in adolescence and adulthood. Therefore, we evaluated the long-term outcomes within the Japanese CDH Study Group (JCDHSG). Methods: Participants were born with CDH between 2006 and 2018 according to the JCDHSG. Participants were enrolled in the database at 1.5, 3, 6, and 12 years old. Follow-up items included long-term complications, operations for long-term complication, and home medical care. Results: A total of 747 patients were included in this study, with 626 survivors (83.8%) and 121 non-survivors (16.2%). At 1.5, 3, 6, and 12 years old, 45.4%, 36.5%, 34.8%, and 43.6% developed complications, and 20.1%, 14.7%, 11.5%, and 5.1% of participants required home care, respectively. Recurrence, pneumonia, pneumothorax, gastroesophageal reflux disease, and intestinal obstruction decreased with age, and thoracic deformity increased with age. Conclusions: As CDH survival rates improve, there is a need for continued research and fine-tuning of long-term care to optimize appropriate surveillance and long-term follow-up.

2 December 2023 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
SFShigehisa Fumino
Shigehisa Fumino
YHYoshiaki Hirohata
Yoshiaki Hirohata
STShohei Takayama
Shohei Takayama
TTTatsuro Tajiri
Tatsuro Tajiri
NUNoriaki Usui
Noriaki Usui
YAYuhki Arai
Yuhki Arai

1 December 2010 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
NUNoriaki Usui
Noriaki Usui
TKTakeshi Kanagawa
Takeshi Kanagawa
MKMasafumi Kamiyama
Masafumi Kamiyama
GTGakuto Tani
Gakuto Tani
YKYukiko Kinugasa-Taniguchi
Yukiko Kinugasa-Taniguchi
MFMasahiro Fukuzawa
Masahiro Fukuzawa

29 January 2024 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
KMKazunori Masahata
Kazunori Masahata
KNKouji Nagata
Kouji Nagata
KTKeita Terui
Keita Terui
TKTakuya Kondo
Takuya Kondo
AEAshley H. Ebanks
Ashley H. Ebanks
NUNoriaki Usui
Noriaki Usui

21 July 2023 in Clinical Nutrition ESPEN
Verified
Journal Article
Closed access
MZMasahiro Zenitani
Masahiro Zenitani
YSYoshiyuki Shimizu
Yoshiyuki Shimizu
MYMasayuki Yoshida
Masayuki Yoshida
YNYuki Noguchi
Yuki Noguchi
RMRei Matsuura
Rei Matsuura
NUNoriaki Usui
Noriaki Usui

6 September 2021 in Pediatric Surgery International
Verified
Journal Article
Open access
PDF file
KTKeita Terui
Keita Terui
TFTaizo Furukawa
Taizo Furukawa
KNKouji Nagata
Kouji Nagata
MHMasahiro Hayakawa
Masahiro Hayakawa
HOHiroomi Okuyama
Hiroomi Okuyama
NUNoriaki Usui
Noriaki Usui
Purpose Predicting lethal pulmonary hypoplasia in infants with congenital diaphragmatic hernia (CDH) before extracorporeal membrane oxygenation (ECMO) initiation is difficult. This study aimed to predict lethal pulmonary hypoplasia in patients with CDH prior to ECMO. Methods This was a multicenter cohort study involving neonates prenatally diagnosed with isolated unilateral CDH (born 2006–2020). Patients who required ECMO due to respiratory insufficiency were included in this study. Patients who underwent ECMO due to transient disorders were excluded from analysis. Blood gas analysis data within 24 h of birth were compared between survivors and non-survivors. Predictive abilities were assessed for factors with significant differences. Results Overall, 34 patients were included (18 survivors and 16 non-survivors). The best pre-ductal PaO2 was significantly lower in non-survivors than in survivors (50.4 [IQR 30.3–64.5] vs. 67.5 [IQR 52.4–103.2] mmHg, respectively; p = 0.047). A cutoff PaO2 of 42.9 mmHg had a sensitivity, specificity, and positive predictive value of 50.0%, 94.4%, and 88.9%, respectively, to predict mortality. Conclusion The best PaO2 within 24 h after birth predicted mortality following ECMO initiation. This should be shared to families and caregivers to optimize the best interests of the infants with CDH.